COX
COX(环氧合酶)
COX (cyclooxygenase) is an enzyme that is responsible for formation of important biological mediators called prostanoids, including prostaglandins, prostacyclin and thromboxane.
COX 相关产品(291)
- GC47639Metamizole-d3 (sodium salt)CAS: 2512223-60-6纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47734Nabumetone-d3CAS: 1216770-08-9纯度: >99.00%
An internal standard for the quantification of nabumetone
- GC48232Valdecoxib-d3CAS: 1219794-90-7纯度: >99.00%
An internal standard for the quantification of valdecoxib
- GC48639Lornoxicam-d4CAS: 1216527-48-8纯度: >99.00%
An internal standard for the quantification of lornoxicam
- GC48827Flufenamic Acid-d4CAS: 1185071-99-1纯度: >99.00%
An internal standard for the quantification of flufenamic acid
- GC49054Oxaprozin-d5CAS: 2933758-40-6纯度: >99.00%
An internal standard for the quantification of oxaprozin
- GC49128Phenylbutazone-d9CAS: 1189479-75-1纯度: >99.00%
An internal standard for the quantification of phenylbutazone
- GC49316O-Desmethyl-N-deschlorobenzoyl IndomethacinCAS: 50995-53-4纯度: >95.00%
A metabolite of indomethacin
- GC49480Salicylic Acid-d4CAS: 78646-17-0纯度: >99.00% / >98.00%
An internal standard for the quantification of salicylic acid
- GC49515(±)-Ibuprofen-d3 (sodium salt)CAS: 1219805-09-0纯度: >99.00%
An internal standard for the quantification of (±)-ibuprofen
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC47287 | Eltenac | 72895-88-6 | >98.00% | |
A non-selective COX inhibitor | ||||
| GC47528 | Ketorolac (calcium salt) | 167105-81-9 | >98.00% | |
An NSAID and COX inhibitor | ||||
| GC47639 | Metamizole-d3 (sodium salt) | 2512223-60-6 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47734 | Nabumetone-d3 | 1216770-08-9 | >99.00% | |
An internal standard for the quantification of nabumetone | ||||
| GC48232 | Valdecoxib-d3 | 1219794-90-7 | >99.00% | |
An internal standard for the quantification of valdecoxib | ||||
| GC48639 | Lornoxicam-d4 | 1216527-48-8 | >99.00% | |
An internal standard for the quantification of lornoxicam | ||||
| GC48677 | Sulindac-d3 | - | >99.00% | |
An internal standard for the quantification of sulindac | ||||
| GC48827 | Flufenamic Acid-d4 | 1185071-99-1 | >99.00% | |
An internal standard for the quantification of flufenamic acid | ||||
| GC49054 | Oxaprozin-d5 | 2933758-40-6 | >99.00% | |
An internal standard for the quantification of oxaprozin | ||||
| GC49098 | Olsalazine-13C6 | - | >98.00% | |
An internal standard for the quantification of olsalazine | ||||
| GC49119 | 5-hydroxy Flunixin | 75369-61-8 | >95.00% | |
A metabolite of flunixin | ||||
| GC49128 | Phenylbutazone-d9 | 1189479-75-1 | >99.00% | |
An internal standard for the quantification of phenylbutazone | ||||
| GC49152 | Celecoxib Carboxylic Acid | 170571-01-4 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49156 | Etodolac Acyl Glucuronide | 79541-43-8 | >90.00% | |
A phase II metabolite of etodolac | ||||
| GC49179 | (S)-O-Desmethyl Naproxen | 52079-10-4 | >98.00% | |
A metabolite of (S)-naproxen | ||||
| GC49183 | 6-hydroxy Etodolac | 101901-06-8 | >90.00% | |
A metabolite of etodolac | ||||
| GC49315 | 5-hydroxy Indomethacin | 2504-32-7 | >98.00% | |
A metabolite of indomethacin | ||||
| GC49316 | O-Desmethyl-N-deschlorobenzoyl Indomethacin | 50995-53-4 | >95.00% | |
A metabolite of indomethacin | ||||
| GC49363 | Salicyluric Acid | 487-54-7 | >95.00% | |
A major metabolite of aspirin and salicylic acid | ||||
| GC49366 | 1-Salicylate Glucuronide | 7695-70-7 | >95.00% | |
A metabolite of salicylic acid and aspirin | ||||
| GC49386 | Tepoxalin | 103475-41-8 | >98.00% | |
A dual inhibitor of COX and 5-LO | ||||
| GC49480 | Salicylic Acid-d4 | 78646-17-0 | >99.00% / >98.00% | |
An internal standard for the quantification of salicylic acid | ||||
| GC49515 | (±)-Ibuprofen-d3 (sodium salt) | 1219805-09-0 | >99.00% | |
An internal standard for the quantification of (±)-ibuprofen | ||||
| GC49698 | Indomethacin Acyl Glucuronide | 75523-11-4 | >90.00% | |
A metabolite of indomethacin | ||||